Overexpression of CARMA3 is associated with advanced tumor stage, cell cycle progression, and cisplatin resistance in human epithelial ovarian cancer

Clinical significance and biological roles of CARMA3 in human bladder carcinoma

(2014) Xiaojun Man et al.   TUMOR BIOLOGY

Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer

(2013) Xin-yan Wang et al.   TUMOR BIOLOGY

Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3

(2013) Saeid Shirali et al.   TUMOR BIOLOGY

Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer

(2013) Ya-Feng Wang et al.   TUMOR BIOLOGY

CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells

(2013) Tingting Zhao et al.   TUMOR BIOLOGY

Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma

(2013) Guang-Li Wu et al.   TUMOR BIOLOGY

CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line

(2013) Xingjun Feng et al.   TUMOR BIOLOGY

CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression

(2012) Zhifeng Miao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Overexpression of CARMA3 in Non-Small-Cell Lung Cancer Is Linked for Tumor Progression

(2012) Zixuan Li et al.   PLoS One

Clinical implications of REST and TUBB3 in ovarian cancer and its relationship to paclitaxel resistance

(2012) Song Gao et al.   TUMOR BIOLOGY

An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions

(2012) Ronalds Macuks et al.   TUMOR BIOLOGY

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

(2012) Teresa Granato et al.   TUMOR BIOLOGY

CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis

(2012) Yuanyuan Fang et al.   TUMOR BIOLOGY

Does HE4 have a role as biomarker in the recurrence of ovarian cancer?

(2012) Francesco Plotti et al.   TUMOR BIOLOGY

CARMA3 is Crucial for EGFR-Induced Activation of NF- B and Tumor Progression

(2011) T. Jiang et al.   CANCER RESEARCH

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Translational research in the Gynecologic Oncology Group: Evaluation of ovarian cancer markers, profiles, and novel therapies

(2010) Kathleen M. Darcy et al.   GYNECOLOGIC ONCOLOGY

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment

(2010) E. Despierre et al.   GYNECOLOGIC ONCOLOGY

Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells

(2009) C. P. Masamha et al.   CANCER RESEARCH